Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
Flagship Pioneering’s $3.6 Billion Fundraising
ARCH Venture Fund XII’s $2.975 Billion Fundraising
Proskauer advised ARCH Venture Partners on the transaction. ARCH Venture Partners (“ARCH”) announced the closing of ARCH Venture Fund XII. The fund closed with $2.975 billion...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...